Search for a trial

1 results

Clinical Investigation of the VytronUS Ablation System for Treatment
of Symptomatic Drug-refractory Paroxysmal Atrial Fibrillation

Approved WMORecruitment stopped

Safety: To provide scientific evidence that use of the VAS is safe as measured by the incidence of early-onset serious adverse events (SAEs).Effectiveness: To provide scientific evidence that use of the VAS provides an effective treatment for…

Clinical Investigation of the VytronUS Ablation System for Treatment of Symptomatic Drug-refractory Paroxysmal Atrial Fibrillation

Clinical Investigation of the VytronUS Ablation System for Treatment
of Symptomatic Drug-refractory Paroxysmal Atrial Fibrillation